EKF Diagnostics (LON:EKF – Get Free Report) issued its earnings results on Tuesday. The company reported GBX 0.54 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Trading Up 1.2%
EKF Diagnostics stock traded up GBX 0.30 during mid-day trading on Friday, hitting GBX 26. 7,569,254 shares of the company’s stock were exchanged, compared to its average volume of 366,829. The company’s 50 day simple moving average is GBX 25.45 and its 200-day simple moving average is GBX 25.51. The company has a quick ratio of 1.77, a current ratio of 4.72 and a debt-to-equity ratio of 2.09. The firm has a market capitalization of £111.32 million, a P/E ratio of 55.32 and a beta of 0.50. EKF Diagnostics has a fifty-two week low of GBX 22 and a fifty-two week high of GBX 31.70.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Articles
- Five stocks we like better than EKF Diagnostics
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
